# Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

> **NCT04442724** · NA · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Bladder Cancer
- Urinary Bladder Neoplasm
- Urologic Neoplasms
- Neoplasms
- Urinary Bladder Diseases

## Interventions

- **PROCEDURE:** Fiducial marker placement
- **DIAGNOSTIC_TEST:** Multiparametric MRI (mpMRI)

## Key facts

- **NCT ID:** NCT04442724
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04442724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04442724, "Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04442724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*